Skip to main content
Erschienen in: Endocrine 3/2017

12.04.2017 | Original Article

Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series

verfasst von: Francesco Fallo, Isabella Castellano, Celso E. Gomez-Sanchez, Yara Rhayem, Catia Pilon, Valentina Vicennati, Donatella Santini, Valeria Maffeis, Ambrogio Fassina, Paolo Mulatero, Felix Beuschlein, Martin Reincke

Erschienen in: Endocrine | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion are reported in an increasing number of patients. Five aldosterone-producing adenomas from patients with primary aldosteronism and subclinical hypercortisolism were examined. The aims of our study were: (1) to analyze pathological features and immunohistochemical expression of CYP11B1 (11β-hydroxylase) and CYP11B2 (aldosterone synthase) in these tumors; (2) to investigate somatic mutations involved in adrenal steroid hypersecretion and/or tumor growth.

Methods

Archival micro-dissected paraffin-embedded slides from tumor specimens were used for histological and molecular studies. Immunohistochemistry was performed using monoclonal anti-CYP11B1 and anti-CYP11B2 antibodies. Cellular composition was determined by examining for known features of zona fasciculata and zona glomerulosa, and immunoreactivity for CYP11B1 and CYP11B2 by McCarty H-score. Spot regions for mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, PRKACA, and CTNNB1 gene sequences were evaluated.

Results

Four APAs showed a predominant (≥50%) zona fasciculata-like cell pattern: one tumor had CYP11B1 H-score = 150, no detectable CYP11B2 expression, and harbored a PRKACA p.Leu206Arg mutation (that we have reported previously elsewhere), one had no CYP11B1 expression, CYP11B2 H-score = 40, and no mutations; the remaining two adenomas had high CYP11B1 H-score (160 and 240, respectively) and low CYP11B2 H-score (30 and 15, respectively), with the latter harboring a CTNNB1 p.Ser45Phe activating mutation. One of five aldosterone-producing adenomas had a predominant zona glomerulosa-like pattern, CYP11B1 H-score = 15, CYP11B2 H-score = 180, and no mutations.

Conclusions

The majority of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion were composed mainly of zona fasciculata-like cells, while CYP11B1 and CYP11B2 immunostaining demonstrated clear heterogeneity. In a subset of cases, different somatic mutations may be involved in hormone excess and tumor formation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat M.J. Hogan, M. Schambelan, E.G. Biglieri, Concurrent hypercortisolism and hypermineralocorticoidism. Am. J. Med. 62, 777–782 (1977)CrossRefPubMed M.J. Hogan, M. Schambelan, E.G. Biglieri, Concurrent hypercortisolism and hypermineralocorticoidism. Am. J. Med. 62, 777–782 (1977)CrossRefPubMed
2.
Zurück zum Zitat M. Späth, S. Korovkin, C. Antke, M. Anlauf, H.S. Willenberg, Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. Eur. J. Endocrinol. 164, 447–455 (2011)CrossRefPubMed M. Späth, S. Korovkin, C. Antke, M. Anlauf, H.S. Willenberg, Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. Eur. J. Endocrinol. 164, 447–455 (2011)CrossRefPubMed
3.
Zurück zum Zitat V. Vicennati, A. Repaci, G. di Dalmazi, E. Rinaldi, R. Golfieri, E. Giampalma, F. Minni, N. Marrano, D. Santini, R. Pasquali, Combined aldosterone and cortisol secretion by adrenal incidentaloma. Int. J. Surg. Pathol. 20, 316–319 (2012)CrossRefPubMed V. Vicennati, A. Repaci, G. di Dalmazi, E. Rinaldi, R. Golfieri, E. Giampalma, F. Minni, N. Marrano, D. Santini, R. Pasquali, Combined aldosterone and cortisol secretion by adrenal incidentaloma. Int. J. Surg. Pathol. 20, 316–319 (2012)CrossRefPubMed
4.
Zurück zum Zitat M. Yamada, Y. Nakajima, R. Taguchi, T. Okamura, S. Ishii, T. Tomaru, A. Ozawa, N. Shibusawa, S. Yoshino, A. Toki, E. Ishida, K. Hashimoto, T. Satoh, M. Mori, KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735–774 (2012)CrossRefPubMed M. Yamada, Y. Nakajima, R. Taguchi, T. Okamura, S. Ishii, T. Tomaru, A. Ozawa, N. Shibusawa, S. Yoshino, A. Toki, E. Ishida, K. Hashimoto, T. Satoh, M. Mori, KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735–774 (2012)CrossRefPubMed
5.
Zurück zum Zitat F. Fallo, C. Bertello, D. Tizzani, A. Fassina, S. Boulkroun, N. Sonino, S. Monticone, A. Viola, F. Veglio, P. Mulatero, Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J. Hypertens. 29, 1773–1777 (2011)CrossRefPubMed F. Fallo, C. Bertello, D. Tizzani, A. Fassina, S. Boulkroun, N. Sonino, S. Monticone, A. Viola, F. Veglio, P. Mulatero, Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J. Hypertens. 29, 1773–1777 (2011)CrossRefPubMed
6.
Zurück zum Zitat K. Hiraishi, T. Yoshimoto, K. Tsuchiya, I. Minami, M. Doi, H. Izumiyama, H. Sasano, Y. Hirata, Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome. Endocr. J. 58, 543–551 (2011)CrossRefPubMed K. Hiraishi, T. Yoshimoto, K. Tsuchiya, I. Minami, M. Doi, H. Izumiyama, H. Sasano, Y. Hirata, Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome. Endocr. J. 58, 543–551 (2011)CrossRefPubMed
7.
Zurück zum Zitat V. Yoon, A. Heyliger, T. Maekawa, H. Sasano, K. Carrick, S. Woodruff, J. Rabaglia, R.J. Auchus, H.K. Ghayee, Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids. Endocrinol. Diabetes Metab. Case Rep. 2013, 130042 (2013)PubMedPubMedCentral V. Yoon, A. Heyliger, T. Maekawa, H. Sasano, K. Carrick, S. Woodruff, J. Rabaglia, R.J. Auchus, H.K. Ghayee, Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids. Endocrinol. Diabetes Metab. Case Rep. 2013, 130042 (2013)PubMedPubMedCentral
8.
Zurück zum Zitat K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama, Primary aldosteronism associated with subclinical Cushing syndrome. J. Endocrinol. Invest. 36, 564–567 (2013)PubMed K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama, Primary aldosteronism associated with subclinical Cushing syndrome. J. Endocrinol. Invest. 36, 564–567 (2013)PubMed
9.
Zurück zum Zitat K.Y. Chang, S. Ryu, J.Y. Cho, H.W. Kim, Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome. Korean J. Intern. Med. 29, 679–682 (2014)CrossRefPubMedPubMedCentral K.Y. Chang, S. Ryu, J.Y. Cho, H.W. Kim, Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome. Korean J. Intern. Med. 29, 679–682 (2014)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Y. Nakajima, M. Yamada, R. Taguchi, T. Satoh, K. Hashimoto, A. Ozawa, N. Shibusawa, S. Okada, T. Monden, M. Mori, Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 96, 2512–2518 (2011)CrossRefPubMed Y. Nakajima, M. Yamada, R. Taguchi, T. Satoh, K. Hashimoto, A. Ozawa, N. Shibusawa, S. Okada, T. Monden, M. Mori, Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 96, 2512–2518 (2011)CrossRefPubMed
11.
Zurück zum Zitat A. Prejbisz, E. Warchoł-Celińska, J.W. Lenders, A. Januszewicz, Cardiovascular risk in rimary hyperaldosteronism. Horm. Metab. Res. 47, 973–980 (2015)CrossRefPubMed A. Prejbisz, E. Warchoł-Celińska, J.W. Lenders, A. Januszewicz, Cardiovascular risk in rimary hyperaldosteronism. Horm. Metab. Res. 47, 973–980 (2015)CrossRefPubMed
12.
Zurück zum Zitat G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)CrossRefPubMed G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)CrossRefPubMed
13.
Zurück zum Zitat G.P. Piaditis, G.A. Kaltsas, I.I. Androulakis, A. Gouli, P. Makras, D. Papadogias, K. Dimitriou, D. Ragkou, A. Markou, K. Vamvakidis, G. Zografos, G. Chrousos, High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin. Endocrinol. (Oxf). 71, 772–778 (2009)CrossRefPubMed G.P. Piaditis, G.A. Kaltsas, I.I. Androulakis, A. Gouli, P. Makras, D. Papadogias, K. Dimitriou, D. Ragkou, A. Markou, K. Vamvakidis, G. Zografos, G. Chrousos, High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin. Endocrinol. (Oxf). 71, 772–778 (2009)CrossRefPubMed
14.
Zurück zum Zitat S. Monticone, T. Else, P. Mulatero, T.A. Williams, W.E. Rainey, Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol. Cell. Endocrinol. 399, 311–320 (2015)CrossRefPubMed S. Monticone, T. Else, P. Mulatero, T.A. Williams, W.E. Rainey, Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol. Cell. Endocrinol. 399, 311–320 (2015)CrossRefPubMed
15.
Zurück zum Zitat U.I. Scholl, J.M. Healy, A. Thiel, A.L. Fonseca, T.C. Brown, J.W. Kunstman, M.J. Horne, D. Dietrich, J. Riemer, S. Kücükköylü, E.N. Reimer, A.C. Reis, G. Goh, G. Kristiansen, A. Mahajan, R. Korah, R.P. Lifton, M.L. Prasad, T. Carling, Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin. Endocrinol. (Oxf). 83, 779–789 (2015)CrossRefPubMedPubMedCentral U.I. Scholl, J.M. Healy, A. Thiel, A.L. Fonseca, T.C. Brown, J.W. Kunstman, M.J. Horne, D. Dietrich, J. Riemer, S. Kücükköylü, E.N. Reimer, A.C. Reis, G. Goh, G. Kristiansen, A. Mahajan, R. Korah, R.P. Lifton, M.L. Prasad, T. Carling, Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin. Endocrinol. (Oxf). 83, 779–789 (2015)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat A.E. Teo, S. Garg, L.H. Shaikh, J. Zhou, F.E. Karet Frankl, M. Gurnell, L. Happerfield, A. Marker, M. Bienz, E.A. Azizan, M.J. Brown, Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. N. Engl. J. Med. 373, 1429–1436 (2015)CrossRefPubMedPubMedCentral A.E. Teo, S. Garg, L.H. Shaikh, J. Zhou, F.E. Karet Frankl, M. Gurnell, L. Happerfield, A. Marker, M. Bienz, E.A. Azizan, M.J. Brown, Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. N. Engl. J. Med. 373, 1429–1436 (2015)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat T. Åkerström, R. Maharjan, H. Sven Willenberg, K. Cupisti, J. Ip, A. Moser, P. Stålberg, B. Robinson, K. Alexander Iwen, H. Dralle, M.K. Walz, H. Lehnert, S. Sidhu, C. Gomez-Sanchez, P. Hellman, P. Björklund, Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci. Rep. 6, 19546 (2016)CrossRefPubMedPubMedCentral T. Åkerström, R. Maharjan, H. Sven Willenberg, K. Cupisti, J. Ip, A. Moser, P. Stålberg, B. Robinson, K. Alexander Iwen, H. Dralle, M.K. Walz, H. Lehnert, S. Sidhu, C. Gomez-Sanchez, P. Hellman, P. Björklund, Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci. Rep. 6, 19546 (2016)CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat G. Di Dalmazi, C. Kisker, D. Calebiro, M. Mannelli, L. Canu, G. Arnaldi, M. Quinkler, N. Rayes, A. Tabarin, M. Laure Jullié, F. Mantero, B. Rubin, J. Waldmann, D.K. Bartsch, R. Pasquali, M. Lohse, B. Allolio, M. Fassnacht, F. Beuschlein, M. Reincke, Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing’s syndrome: a European multicentric study. J. Clin. Endocrinol. Metab. 99, E2093–E2100 (2014)CrossRefPubMed G. Di Dalmazi, C. Kisker, D. Calebiro, M. Mannelli, L. Canu, G. Arnaldi, M. Quinkler, N. Rayes, A. Tabarin, M. Laure Jullié, F. Mantero, B. Rubin, J. Waldmann, D.K. Bartsch, R. Pasquali, M. Lohse, B. Allolio, M. Fassnacht, F. Beuschlein, M. Reincke, Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing’s syndrome: a European multicentric study. J. Clin. Endocrinol. Metab. 99, E2093–E2100 (2014)CrossRefPubMed
19.
Zurück zum Zitat A. Thiel, A.C. Reis, M. Haase, G. Goh, M. Schott, H.S. Willenberg, U.I. Scholl, PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. Eur. J. Endocrinol. 172, 677–685 (2015)CrossRefPubMed A. Thiel, A.C. Reis, M. Haase, G. Goh, M. Schott, H.S. Willenberg, U.I. Scholl, PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. Eur. J. Endocrinol. 172, 677–685 (2015)CrossRefPubMed
20.
Zurück zum Zitat M. Yamada, Y. Nakajima, R. Taguchi, T. Okamura, S. Ishii, T. Tomaru, A. Ozawa, N. Shibusawa, S. Yoshino, A. Toki, E. Ishida, K. Hashimoto, T. Satoh, M. Mori, KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735–741 (2012)CrossRefPubMed M. Yamada, Y. Nakajima, R. Taguchi, T. Okamura, S. Ishii, T. Tomaru, A. Ozawa, N. Shibusawa, S. Yoshino, A. Toki, E. Ishida, K. Hashimoto, T. Satoh, M. Mori, KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735–741 (2012)CrossRefPubMed
21.
Zurück zum Zitat Y. Rhayem, L.G. Perez-Rivas, A. Dietz, K. Bathon, C. Gebhard, A. Riester, B. Mauracher, C. Gomez-Sanchez, G. Eisenhofer, T. Schwarzmayr, D. Calebiro, T.M. Strom, M. Reincke, F. Beuschlein, PRKACA somatic mutations are rare findings in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 101, 3010–3017 (2016)CrossRefPubMed Y. Rhayem, L.G. Perez-Rivas, A. Dietz, K. Bathon, C. Gebhard, A. Riester, B. Mauracher, C. Gomez-Sanchez, G. Eisenhofer, T. Schwarzmayr, D. Calebiro, T.M. Strom, M. Reincke, F. Beuschlein, PRKACA somatic mutations are rare findings in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 101, 3010–3017 (2016)CrossRefPubMed
22.
Zurück zum Zitat J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889–1916 (2016)CrossRefPubMed J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889–1916 (2016)CrossRefPubMed
23.
Zurück zum Zitat R. Goupil, M. Wolley, A.H. Ahmed, R.D. Gordon, M. Stowasser, Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism ? Clin. Endocrinol. (Oxf). 83, 456–461 (2015)CrossRefPubMed R. Goupil, M. Wolley, A.H. Ahmed, R.D. Gordon, M. Stowasser, Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism ? Clin. Endocrinol. (Oxf). 83, 456–461 (2015)CrossRefPubMed
24.
Zurück zum Zitat M. Kishino, T. Yoshimoto, M. Nakadate, Y. Katada, E. Kanda, S. Nakaminato, Y. Saida, Y. Ogawa, U. Tateishi, Optimization of left adrenal vein sampling in primary aldosteronism: coping with asymmetrical cortisol secretion. Endocr. J. (2017). doi:10.1507/endocrj.EJ16-0433. PubMed PMID: 28132968 M. Kishino, T. Yoshimoto, M. Nakadate, Y. Katada, E. Kanda, S. Nakaminato, Y. Saida, Y. Ogawa, U. Tateishi, Optimization of left adrenal vein sampling in primary aldosteronism: coping with asymmetrical cortisol secretion. Endocr. J. (2017). doi:10.​1507/​endocrj.​EJ16-0433. PubMed PMID: 28132968
25.
Zurück zum Zitat P. Mulatero, F. Veglio, C. Pilon, F. Rabbia, C. Zocchi, P. Limone, M. Boscaro, N. Sonino, F. Fallo, Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J. Clin. Endocrinol. Metab. 83, 2573–2575 (1998)CrossRefPubMed P. Mulatero, F. Veglio, C. Pilon, F. Rabbia, C. Zocchi, P. Limone, M. Boscaro, N. Sonino, F. Fallo, Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J. Clin. Endocrinol. Metab. 83, 2573–2575 (1998)CrossRefPubMed
26.
Zurück zum Zitat L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)CrossRefPubMedPubMedCentral L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat P. Mulatero, A. Milan, F. Fallo, G. Regolisti, F. Pizzolo, C. Fardella, L. Mosso, L. Marafetti, F. Veglio, M. Maccario, Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 91, 2618–2623 (2006)CrossRefPubMed P. Mulatero, A. Milan, F. Fallo, G. Regolisti, F. Pizzolo, C. Fardella, L. Mosso, L. Marafetti, F. Veglio, M. Maccario, Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 91, 2618–2623 (2006)CrossRefPubMed
28.
Zurück zum Zitat J. Manolopoulou, E. Fischer, A. Dietz, S. Diederich, D. Holmes, R. Junnila, P. Grimminger, M. Reincke, A. Morganti, M. Bidlingmaier, Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J. Hypertens. 33, 2500–2511 (2015)CrossRefPubMed J. Manolopoulou, E. Fischer, A. Dietz, S. Diederich, D. Holmes, R. Junnila, P. Grimminger, M. Reincke, A. Morganti, M. Bidlingmaier, Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J. Hypertens. 33, 2500–2511 (2015)CrossRefPubMed
30.
Zurück zum Zitat A.M. Neville, M.J. O’Hare, Histopathology of the human adrenal cortex. Clin. Endocrinol. Metab. 14, 791–820 (1985).CrossRefPubMed A.M. Neville, M.J. O’Hare, Histopathology of the human adrenal cortex. Clin. Endocrinol. Metab. 14, 791–820 (1985).CrossRefPubMed
31.
Zurück zum Zitat Y. Nakamura., S.J. Felizola, F. Satoh, S. Konosu-Fukaya, H. Sasano, Dissecting the molecular pathways of primary aldosteronism. Pathol. Int. 64, 482–489 (2014)CrossRefPubMed Y. Nakamura., S.J. Felizola, F. Satoh, S. Konosu-Fukaya, H. Sasano, Dissecting the molecular pathways of primary aldosteronism. Pathol. Int. 64, 482–489 (2014)CrossRefPubMed
32.
Zurück zum Zitat C.E. Gomez-Sanchez, X. Qi, C. Velarde-Miranda, M.W. Plonczynski, C.R. Parker, W. Rainey, F. Satoh, T. Maekawa, Y. Nakamura, H. Sasano, E.P. Gomez-Sanchez, Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol. Cell. Endocrinol. 383, 111–117 (2014)CrossRefPubMed C.E. Gomez-Sanchez, X. Qi, C. Velarde-Miranda, M.W. Plonczynski, C.R. Parker, W. Rainey, F. Satoh, T. Maekawa, Y. Nakamura, H. Sasano, E.P. Gomez-Sanchez, Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol. Cell. Endocrinol. 383, 111–117 (2014)CrossRefPubMed
33.
Zurück zum Zitat K.S. McCarty Jr., L.S. Miller, E.B. Cox, J. Konrath, K.S. McCarty Sr., Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716–721 (1985)PubMed K.S. McCarty Jr., L.S. Miller, E.B. Cox, J. Konrath, K.S. McCarty Sr., Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716–721 (1985)PubMed
34.
Zurück zum Zitat D.A. Budwit-Novotny, K.S. McCarty, E.B. Cox, J.T. Soper, D.G. Mutch, W.T. Creasman, I.L. Flowers, K.S. McCarty Jr., Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 46, 5419–5425 (1986)PubMed D.A. Budwit-Novotny, K.S. McCarty, E.B. Cox, J.T. Soper, D.G. Mutch, W.T. Creasman, I.L. Flowers, K.S. McCarty Jr., Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 46, 5419–5425 (1986)PubMed
35.
Zurück zum Zitat Y. Ono, Y. Nakamura, T. Maekawa, S.J. Felizola, R. Morimoto, Y. Iwakura, M. Kudo, K. Seiji, K. Takase, Y. Arai, C.E. Gomez-Sanchez, S. Ito, H. Sasano, F. Satoh, Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension 64, 438–444 (2014)CrossRefPubMedPubMedCentral Y. Ono, Y. Nakamura, T. Maekawa, S.J. Felizola, R. Morimoto, Y. Iwakura, M. Kudo, K. Seiji, K. Takase, Y. Arai, C.E. Gomez-Sanchez, S. Ito, H. Sasano, F. Satoh, Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension 64, 438–444 (2014)CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat F.L. Fernandes-Rosa, T.A. Williams, A. Riester, O. Steichen, F. Beuschlein, S. Boulkroun, T.M. Strom, S. Monticone, L. Amar, Y. Meatchi, F. Mantero, M.V. Cicala, M. Quinkler, F. Fallo, B. Allolio, G. Bernini, M. Maccario, G. Giacchetti, X. Jeunemaitre, P. Mulatero, M. Reincke, M.C. Zennaro, Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354–361 (2014)CrossRefPubMed F.L. Fernandes-Rosa, T.A. Williams, A. Riester, O. Steichen, F. Beuschlein, S. Boulkroun, T.M. Strom, S. Monticone, L. Amar, Y. Meatchi, F. Mantero, M.V. Cicala, M. Quinkler, F. Fallo, B. Allolio, G. Bernini, M. Maccario, G. Giacchetti, X. Jeunemaitre, P. Mulatero, M. Reincke, M.C. Zennaro, Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354–361 (2014)CrossRefPubMed
37.
Zurück zum Zitat T.A. Williams, S. Monticone, V.R. Schack, J. Stindl, J. Burrello, F. Buffolo, L. Annaratone, I. Castellano, F. Beuschlein, M. Reincke, B. Lucatello, V. Ronconi, F. Fallo, G. Bernini, M. Maccario, G. Giacchetti, F. Veglio, R. Warth, B. Vilsen, P. Mulatero, Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension 63, 188–195 (2014)CrossRefPubMed T.A. Williams, S. Monticone, V.R. Schack, J. Stindl, J. Burrello, F. Buffolo, L. Annaratone, I. Castellano, F. Beuschlein, M. Reincke, B. Lucatello, V. Ronconi, F. Fallo, G. Bernini, M. Maccario, G. Giacchetti, F. Veglio, R. Warth, B. Vilsen, P. Mulatero, Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension 63, 188–195 (2014)CrossRefPubMed
38.
Zurück zum Zitat S. Bonnet, S. Gaujoux, P. Launay, C. Baudry, I. Chokri, B. Ragazzon, R. Libé, F. René-Corail, A. Audebourg, M.C. Vacher-Lavenu, L. Groussin, X. Bertagna, B. Dousset, J. Bertherat, F. Tissier, Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J. Clin. Endocrinol. Metab. 96, E419–E426 (2011)CrossRefPubMed S. Bonnet, S. Gaujoux, P. Launay, C. Baudry, I. Chokri, B. Ragazzon, R. Libé, F. René-Corail, A. Audebourg, M.C. Vacher-Lavenu, L. Groussin, X. Bertagna, B. Dousset, J. Bertherat, F. Tissier, Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J. Clin. Endocrinol. Metab. 96, E419–E426 (2011)CrossRefPubMed
39.
Zurück zum Zitat F. Fallo, V. Pezzi, L. Barzon, P. Mulatero, F. Veglio, N. Sonino, J.M. Mathis, Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur. J. Endocrinol. 147, 795–802 (2002)CrossRefPubMed F. Fallo, V. Pezzi, L. Barzon, P. Mulatero, F. Veglio, N. Sonino, J.M. Mathis, Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur. J. Endocrinol. 147, 795–802 (2002)CrossRefPubMed
40.
Zurück zum Zitat H. Fujii, K. Kamide, O. Miyake, T. Abe, M. Nagai, H. Nakahama, T. Horio, S. Takiuchi, A. Okuyama, C. Yutani, Y. Kawano, Primary aldosteronism combined with preclinical Cushing’s syndrome in an elderly patient. Circ. J. 69, 1425–1427 (2005)CrossRefPubMed H. Fujii, K. Kamide, O. Miyake, T. Abe, M. Nagai, H. Nakahama, T. Horio, S. Takiuchi, A. Okuyama, C. Yutani, Y. Kawano, Primary aldosteronism combined with preclinical Cushing’s syndrome in an elderly patient. Circ. J. 69, 1425–1427 (2005)CrossRefPubMed
41.
Zurück zum Zitat Y. Nakamura, T. Maekawa, S.J. Felizola, F. Satoh, X. Qi, C. Velarde-Miranda, M.W. Plonczynski, K. Ise, K. Kikuchi, W.E. Rainey, E.P. Gomez-Sanchez, C.E. Gomez-Sanchez, H. Sasano, Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol. Cell. Endocrinol. 392, 73–79 (2014)CrossRefPubMedPubMedCentral Y. Nakamura, T. Maekawa, S.J. Felizola, F. Satoh, X. Qi, C. Velarde-Miranda, M.W. Plonczynski, K. Ise, K. Kikuchi, W.E. Rainey, E.P. Gomez-Sanchez, C.E. Gomez-Sanchez, H. Sasano, Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol. Cell. Endocrinol. 392, 73–79 (2014)CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat S. Monticone, I. Castellano, K. Versace, B. Lucatello, F. Veglio, C.E. Gomez-Sanchez, T.A. Williams, P. Mulatero, Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol. Cell. Endocrinol. 411, 146–154 (2015)CrossRefPubMedPubMedCentral S. Monticone, I. Castellano, K. Versace, B. Lucatello, F. Veglio, C.E. Gomez-Sanchez, T.A. Williams, P. Mulatero, Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol. Cell. Endocrinol. 411, 146–154 (2015)CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat L. Lenzini, T.M. Seccia, E. Aldighieri, A.S. Belloni, P. Bernante, L. Giuliani, G.G. Nussdorfer, A.C. Pessina, G.P. Rossi, Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50, 1106–1113 (2007)CrossRefPubMed L. Lenzini, T.M. Seccia, E. Aldighieri, A.S. Belloni, P. Bernante, L. Giuliani, G.G. Nussdorfer, A.C. Pessina, G.P. Rossi, Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50, 1106–1113 (2007)CrossRefPubMed
44.
Zurück zum Zitat T. Dekkers, M. ter Meer, J.W. Lenders, A.R. Hermus, L.S. Kool, J.F. Langenhuijsen, K. Nishimoto, T. Ogishima, K. Mukai, E.A. Azizan, B. Tops, J. Deinum, B. Küsters, Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J. Clin. Endocrinol. Metab. 99, E1341–E1351 (2014)CrossRefPubMed T. Dekkers, M. ter Meer, J.W. Lenders, A.R. Hermus, L.S. Kool, J.F. Langenhuijsen, K. Nishimoto, T. Ogishima, K. Mukai, E.A. Azizan, B. Tops, J. Deinum, B. Küsters, Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J. Clin. Endocrinol. Metab. 99, E1341–E1351 (2014)CrossRefPubMed
45.
Zurück zum Zitat E.A. Azizan, B.Y. Lam, S.J. Newhouse, J. Zhou, R.E. Kuc, J. Clarke, L. Happerfield, A. Marker, G.J. Hoffman, M.J. Brown, Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J. Clin. Endocrinol. Metab. 97, E819–E829 (2012)CrossRefPubMed E.A. Azizan, B.Y. Lam, S.J. Newhouse, J. Zhou, R.E. Kuc, J. Clarke, L. Happerfield, A. Marker, G.J. Hoffman, M.J. Brown, Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J. Clin. Endocrinol. Metab. 97, E819–E829 (2012)CrossRefPubMed
47.
Zurück zum Zitat N.G. Hattangady, S. Karashima, L. Yuan, D. Ponce-Balbuena, J. Jalife, C.E. Gomez- Sanchez, R.J. Auchus, W.E. Rainey, T. Else, Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production. J. Mol. Endocrinol. 57, 1–11 (2016)CrossRefPubMedPubMedCentral N.G. Hattangady, S. Karashima, L. Yuan, D. Ponce-Balbuena, J. Jalife, C.E. Gomez- Sanchez, R.J. Auchus, W.E. Rainey, T. Else, Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production. J. Mol. Endocrinol. 57, 1–11 (2016)CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat A. Tong, G. Liu, F. Wang, J. Jiang, Z. Yan, D. Zhang, Y. Zhang, J. Cai, A novel phenotype of familial hyperaldosteronism Type III: concurrence of aldosteronism and Cushing’s syndrome. J. Clin. Endocrinol. Metab. 101, 4290–4297 (2016)CrossRefPubMedPubMedCentral A. Tong, G. Liu, F. Wang, J. Jiang, Z. Yan, D. Zhang, Y. Zhang, J. Cai, A novel phenotype of familial hyperaldosteronism Type III: concurrence of aldosteronism and Cushing’s syndrome. J. Clin. Endocrinol. Metab. 101, 4290–4297 (2016)CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat L.S. Kirschner, Medicine. A unified cause of adrenal Cushing’s syndrome. Science 344, 804–805 (2014)CrossRefPubMed L.S. Kirschner, Medicine. A unified cause of adrenal Cushing’s syndrome. Science 344, 804–805 (2014)CrossRefPubMed
50.
Zurück zum Zitat F. Beuschlein, M. Fassnacht, G. Assié, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)CrossRefPubMedPubMedCentral F. Beuschlein, M. Fassnacht, G. Assié, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Y. Nakajima, T. Okamura, T. Gohko, T. Satoh, K. Hashimoto, N. Shibusawa, A. Ozawa, S. Ishii, T. Tomaru, K. Horiguchi, S. Okada, D. Takata, N. Rokutanda, J. Horiguchi, Y. Tsushima, T. Oyama, I. Takeyoshi, M. Yamada, Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Endocr. J. 61, 825–832 (2014)CrossRefPubMed Y. Nakajima, T. Okamura, T. Gohko, T. Satoh, K. Hashimoto, N. Shibusawa, A. Ozawa, S. Ishii, T. Tomaru, K. Horiguchi, S. Okada, D. Takata, N. Rokutanda, J. Horiguchi, Y. Tsushima, T. Oyama, I. Takeyoshi, M. Yamada, Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Endocr. J. 61, 825–832 (2014)CrossRefPubMed
52.
Zurück zum Zitat A. El Wakil, E. Lalli, The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol. Cell. Endocrinol. 332, 32–37 (2011)CrossRefPubMed A. El Wakil, E. Lalli, The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol. Cell. Endocrinol. 332, 32–37 (2011)CrossRefPubMed
53.
Zurück zum Zitat P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, K.W. Kinzler, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787–1790 (1997)CrossRefPubMed P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, K.W. Kinzler, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787–1790 (1997)CrossRefPubMed
54.
Zurück zum Zitat V.C. Wu, S.M. Wang, S.J. Chueh, S.Y. Yang, K.H. Huang, Y.H. Lin, J.J. Wang, R. Connolly, Y.H. Hu, C.E. Gomez-Sanchez, K.Y. Peng, K.D. Wu, The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes. Sci. Rep. 7, 39121 (2017)CrossRefPubMedPubMedCentral V.C. Wu, S.M. Wang, S.J. Chueh, S.Y. Yang, K.H. Huang, Y.H. Lin, J.J. Wang, R. Connolly, Y.H. Hu, C.E. Gomez-Sanchez, K.Y. Peng, K.D. Wu, The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes. Sci. Rep. 7, 39121 (2017)CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, Y. Tan, Z. Zhang, X. Lin, X. He, Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837–847 (2002)CrossRefPubMed C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, Y. Tan, Z. Zhang, X. Lin, X. He, Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837–847 (2002)CrossRefPubMed
56.
Zurück zum Zitat T. Hagen, A. Vidal-Puig, Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res. Commun. 294, 324–328 (2002)CrossRefPubMed T. Hagen, A. Vidal-Puig, Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res. Commun. 294, 324–328 (2002)CrossRefPubMed
57.
Zurück zum Zitat C.H. Wilson, R.E. McIntyre, M.J. Arends, D.J. Adams, The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc (Min/ +) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene 29, 4567–4575 (2010)CrossRefPubMedPubMedCentral C.H. Wilson, R.E. McIntyre, M.J. Arends, D.J. Adams, The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc (Min/ +) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene 29, 4567–4575 (2010)CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Y. Nakajima, T. Okamura, K. Horiguchi, T. Gohko, T. Miyamoto, T. Satoh, A. Ozawa, S. Ishii, E. Yamada, K. Hashimoto, S. Okada, D. Takata, J. Horiguchi, M. Yamada, GNAS mutations in adrenal aldosterone-producing adenomas. Endocr. J. 63, 199–204 (2016)CrossRefPubMed Y. Nakajima, T. Okamura, K. Horiguchi, T. Gohko, T. Miyamoto, T. Satoh, A. Ozawa, S. Ishii, E. Yamada, K. Hashimoto, S. Okada, D. Takata, J. Horiguchi, M. Yamada, GNAS mutations in adrenal aldosterone-producing adenomas. Endocr. J. 63, 199–204 (2016)CrossRefPubMed
59.
Zurück zum Zitat L. Cazabat, B. Ragazzon, L. Groussin, J. Bertherat, PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary 9, 211–219 (2006)CrossRefPubMed L. Cazabat, B. Ragazzon, L. Groussin, J. Bertherat, PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary 9, 211–219 (2006)CrossRefPubMed
61.
Zurück zum Zitat C.A. Stratakis, E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors. J. Clin. Endocrinol. Metab. 99, 3629–3633 (2014). Erratum in: J. Clin. Endocrinol. Metab. 100, 764 (2015)CrossRefPubMedPubMedCentral C.A. Stratakis, E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors. J. Clin. Endocrinol. Metab. 99, 3629–3633 (2014). Erratum in: J. Clin. Endocrinol. Metab. 100, 764 (2015)CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat J.A. Carney, C. Lyssikatos, M.B. Lodish, C.A. Stratakis, Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes. Hum. Pathol. 46, 40–49 (2015)CrossRef J.A. Carney, C. Lyssikatos, M.B. Lodish, C.A. Stratakis, Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes. Hum. Pathol. 46, 40–49 (2015)CrossRef
63.
Zurück zum Zitat M.B. Lodish, B. Yuan, I. Levy, G.D. Braunstein, C. Lyssikatos, P. Salpea, E. Szarek, A.S. Karageorgiadis, E. Belyavskaya, M. Raygada, F.R. Faucz, L. Izatt, C. Brain, J. Gardner, M. Quezado, J.A. Carney, J.R. Lupski, C.A. Stratakis, Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. Eur. J. Endocrinol. 172, 803–811 (2015)CrossRefPubMedPubMedCentral M.B. Lodish, B. Yuan, I. Levy, G.D. Braunstein, C. Lyssikatos, P. Salpea, E. Szarek, A.S. Karageorgiadis, E. Belyavskaya, M. Raygada, F.R. Faucz, L. Izatt, C. Brain, J. Gardner, M. Quezado, J.A. Carney, J.R. Lupski, C.A. Stratakis, Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. Eur. J. Endocrinol. 172, 803–811 (2015)CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat C.A. Stratakis, J.A. Carney, L.S. Kirschner, H.S. Willenberg, S. Brauer, M. Ehrhart-Bornstein, S.R. Bornstein, Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J. Clin. Endocrinol. Metab. 84, 1122–1128 (1999)CrossRefPubMed C.A. Stratakis, J.A. Carney, L.S. Kirschner, H.S. Willenberg, S. Brauer, M. Ehrhart-Bornstein, S.R. Bornstein, Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J. Clin. Endocrinol. Metab. 84, 1122–1128 (1999)CrossRefPubMed
65.
Zurück zum Zitat J.A. Carney, R. Libé, J. Bertherat, W.F. Young, Primary pigmented nodular adrenocortical disease: the original 4 cases revisited after 30 years for follow-up, new investigations, and molecular genetic findings. Am. J. Surg. Pathol. 38, 1266–1273 (2014)CrossRefPubMed J.A. Carney, R. Libé, J. Bertherat, W.F. Young, Primary pigmented nodular adrenocortical disease: the original 4 cases revisited after 30 years for follow-up, new investigations, and molecular genetic findings. Am. J. Surg. Pathol. 38, 1266–1273 (2014)CrossRefPubMed
66.
Zurück zum Zitat K. Shigematsu, N. Nishida, H. Sakai, T. Igawa, K. Toriyama, A. Nakatani, O. Takahara, K. Kawai, Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression. Eur. J. Endocrinol. 161, 939–945 (2009)CrossRefPubMed K. Shigematsu, N. Nishida, H. Sakai, T. Igawa, K. Toriyama, A. Nakatani, O. Takahara, K. Kawai, Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression. Eur. J. Endocrinol. 161, 939–945 (2009)CrossRefPubMed
67.
Zurück zum Zitat A.R. Sangoi, J.K. McKenney, A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am. J. Surg. Pathol. 34, 423–432 (2010)CrossRefPubMed A.R. Sangoi, J.K. McKenney, A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am. J. Surg. Pathol. 34, 423–432 (2010)CrossRefPubMed
Metadaten
Titel
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series
verfasst von
Francesco Fallo
Isabella Castellano
Celso E. Gomez-Sanchez
Yara Rhayem
Catia Pilon
Valentina Vicennati
Donatella Santini
Valeria Maffeis
Ambrogio Fassina
Paolo Mulatero
Felix Beuschlein
Martin Reincke
Publikationsdatum
12.04.2017
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1295-4

Weitere Artikel der Ausgabe 3/2017

Endocrine 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.